- Home
- SWVL vs ATNM Comparison
SWVL vs ATNM Comparison
Compare SWVL & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- ATNM
- Stock Information
- Founded
- SWVL 2017
- ATNM 2000
- Country
- SWVL United Arab Emirates
- ATNM United States
- Employees
- SWVL N/A
- ATNM N/A
- Industry
- SWVL Business Services
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- SWVL Consumer Discretionary
- ATNM Health Care
- Exchange
- SWVL Nasdaq
- ATNM Nasdaq
- Market Cap
- SWVL 50.6M
- ATNM 51.5M
- IPO Year
- SWVL N/A
- ATNM N/A
- Fundamental
- Price
- SWVL $4.66
- ATNM $1.56
- Analyst Decision
- SWVL
- ATNM Strong Buy
- Analyst Count
- SWVL 0
- ATNM 3
- Target Price
- SWVL N/A
- ATNM $4.67
- AVG Volume (30 Days)
- SWVL 21.3K
- ATNM 229.8K
- Earning Date
- SWVL 06-10-2025
- ATNM 05-09-2025
- Dividend Yield
- SWVL N/A
- ATNM N/A
- EPS Growth
- SWVL N/A
- ATNM N/A
- EPS
- SWVL N/A
- ATNM N/A
- Revenue
- SWVL $17,207,362.00
- ATNM N/A
- Revenue This Year
- SWVL N/A
- ATNM N/A
- Revenue Next Year
- SWVL N/A
- ATNM N/A
- P/E Ratio
- SWVL N/A
- ATNM N/A
- Revenue Growth
- SWVL N/A
- ATNM N/A
- 52 Week Low
- SWVL $2.40
- ATNM $1.03
- 52 Week High
- SWVL $10.87
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- SWVL 62.70
- ATNM 51.11
- Support Level
- SWVL $4.51
- ATNM $1.51
- Resistance Level
- SWVL $4.89
- ATNM $1.69
- Average True Range (ATR)
- SWVL 0.44
- ATNM 0.11
- MACD
- SWVL 0.04
- ATNM -0.02
- Stochastic Oscillator
- SWVL 83.06
- ATNM 36.78
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.